ARTICLE | Company News
Conforma in-licenses Sumitomo's amrubicin
June 30, 2005 1:33 AM UTC
Sumitomo (Osaka, Japan) granted Conforma (San Diego, Calif.) exclusive rights to develop and market amrubicin in North America and Europe. Sumitomo markets the third-generation synthetic anthracycline...